Ex Parte FUTAMURA et alDownload PDFPatent Trials and Appeals BoardMar 20, 201914025550 - (D) (P.T.A.B. Mar. 20, 2019) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE FIRST NAMED INVENTOR 14/025,550 09/12/2013 127226 7590 03/22/2019 BIRCH, STEW ART, KOLASCH & BIRCH, LLP 8110 Gatehouse Road Suite 100 East Falls Church, VA 22042-1248 Tsuyoshi FUTAMURA UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 0042-0675PUS 1 5353 EXAMINER NGUYEN, PHU HOANG ART UNIT PAPER NUMBER 1747 NOTIFICATION DATE DELIVERY MODE 03/22/2019 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): mailroom@bskb.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte TSUYOSHI FUT AMURA, NORIOKAWATA, YOSHIYUKI YAMADA 1 Appeal2018-002396 Application 14/025,550 Technology Center 1700 Before BRADLEY R. GARRIS, ROMULO H. DELMENDO, and MONTE T. SQUIRE, Administrative Patent Judges. GARRIS, Administrative Patent Judge. DECISION ON APPEAL Pursuant to 35 U.S.C. § 134, Appellant appeals from the Examiner's rejection of claims 1, 4, 5, and 11-16 under 35 U.S.C. § 103(a) as unpatentable over Yamada et al. (US 2006/0065279 Al, published Mar. 30, 1 Appellant is the Applicant, JAPAN TOBACCO, INC., which is identified as the real party in interest (App. Br. 1 ). Appeal2018-002396 Application 14/025,550 2006 ("Yamada")) in view of JPl 2 (JP 02-018058 B, published Apr. 24, 1990, as disclosed in the computer translation of record), Kite et al. (US 4,131,117, issued Dec. 26, 1978 ("Kite")), and Fagg (US 5,005,593, issued Apr. 9, 1991). We have jurisdiction under 35 U.S.C. § 6. We AFFIRM. Appellant claims a method of manufacturing a reconstituted tobacco material comprising: subjecting tobacco extracted liquid at a temperature within a range of 40 to 80°C to a fractionating treatment by means of a reverse osmosis membrane to obtain a membrane impermeable fraction containing desired components and depleted in undesired components; and repeatedly performing the fractionating treatment to obtain a concentrated membrane impermeable fraction which includes repeatedly adding process water, wherein the process water is obtained by removing bicarbonate ions from hard water containing bicarbonate ions (sole independent claim 1 ). Further details of the claimed method are set forth in representative claim 1, a copy of which taken from the Claims Appendix of the Appeal Brief appears below. 1. A method of manufacturing a reconstituted tobacco material, compnsmg: 2 We refer to this reference as "JP 1" to be consistent with the Examiner (Final Action 2) and Appellant (App. Br. 6). 2 Appeal2018-002396 Application 14/025,550 (a) extracting a natural tobacco material with an extracting solvent to obtain an extraction residue and a tobacco extracted liquid containing desired components and undesired components including tobacco-specific nitrosamines; (b) subjecting the tobacco extracted liquid to a fractionating treatment by means of a reverse osmosis membrane to obtain a membrane impermeable fraction containing the desired components and depleted in the undesired components and a membrane permeable fraction depleted in the desired components and enriched in the undesired components; ( c) controlling the tobacco extracted liquid during the fractionating treatment to have a temperature within a range of 40 to 80°C; ( d) removing precipitates, which are precipitated in the tobacco extracted liquid during the fractionating treatment, from the tobacco extracted liquid; ( e) preparing a reconstituted tobacco web containing the extraction residue; and (t) adding the membrane impermeable fraction to the reconstituted tobacco web, wherein the step (b) comprises: (b-1) repeatedly performing the fractionating treatment to obtain a concentrated membrane impermeable fraction, and (b-2) repeating a cycle consisting of an addition of process water to the concentrated membrane impermeable fraction and the fractionating treatment of the membrane impermeable fraction supplied with the process water, wherein the process water is obtained by removing bicarbonate ions from hard water containing bicarbonate ions. (App. Br., Claims Appendix pg. 1.) Appellant does not present separate arguments specifically directed to dependent claims 4, 5, and 11-16 (see App. Br. 5-13). Accordingly, these dependent claims will stand or fall with parent independent claim 1. We sustain the Examiner's§ 103 rejection for the reasons given in the Final Office Action, the Examiner's Answer, and below. 3 Appeal2018-002396 Application 14/025,550 In rejecting claim 1, the Examiner finds that Yamada discloses a method of manufacturing a reconstituted tobacco material comprising subjecting tobacco extracted liquid to a fractionating treatment by means of a reverse osmosis membrane to obtain a membrane impermeable fraction containing desired components and depleted in undesired components (Final Action 2-3). The Examiner finds that Yamada does not disclose the claim 1 features of removing precipitates during the fractionating treatment and repeatedly performing the fractionating treatment including the step of repeatedly adding process water (id. at 3--4). The Examiner concludes that it would have been obvious to provide Yamada's method with these features in view of JPl and Kite (id.), and Appellant does not argue otherwise with any reasonable specificity (see App. Br. 5-13). Concerning the process water feature of claim 1, the Examiner concludes that, in view of Fagg, it would have been obvious to use essentially pure water ( which the Examiner equates to the claimed process water3) as the fractionating-treatment process water in the above-modified method of Yamada (Final Action 4). As for the claimed temperature feature, the Examiner concludes that it would have been obvious to perform 3 The Examiner accurately observes that Appellant provides no evidence of a distinction between process water that is essentially pure water and process water "obtained by removing bicarbonate ions from hard water containing bicarbonate ions" ( claim 1) (Final Action 7). Additionally, we emphasize that, because claim 1 does not quantify the amount of removed bicarbonate ions, the claimed process water also is indistinguishable from a hard water with only a slight amount of bicarbonate ions removed. 4 Appeal2018-002396 Application 14/025,550 Yamada's fractionating treatment at an extracted-liquid temperature within a range of 40 to 80°C in view of JP 1 (id. at 5). Appellant states that Yamada considers nicotine a desirable component whereas JP 1 is concerned with removing nicotine from tobacco leaves (App. Br. 8). Appellant argues that, "since Yamada et al[.] and JP[l] address problems completely opposite from each other, such negative teachings would provide no incentive to combine JP 1 with Yamada" (id.). Appellant does not embellish this argument with any explanation why the nicotine teachings of Yamada and JP 1 would have discouraged the Examiner's proposed modification of Yamada' s fractionating treatment to include the temperatures and precipitate-removal taught by JP 1. Such an explanation is necessary because the proposed modifications have no apparent relationship to the desirability versus removal of nicotine. In the record before us, Appellant's argument is little more than an unsupported assertion. Appellant points out that Kite's process water is added "in the middle of the process" whereas Fagg's pure water "is used in the first step of the process of Fagg" (id.). Appellant argues, "a person of ordinary skill in the art would not contemplate using the [pure water] extract solvent of Fagg, as process water to be added to the concentrate, in the middle of the process" (id.). Based on the fact that Fagg also discloses using water having bicarbonates as extract solvent, Appellant additionally argues that "a person of ordinary skill would not conceive using 'water with bicarbonated ions 5 Appeal2018-002396 Application 14/025,550 removed', as process water, since Fagg suggests the opposite to the process water used in the present invention" (id.). These arguments lack persuasive merit. We agree with the Examiner that the combined teachings of Yamada, Kite, and Fagg would have suggested using Fagg's essentially pure water as the process water repeatedly added to Yamada's fractionating treatment in accordance with the teachings of Kite (Final Action 4, 6). Appellant does not address these combined teachings. Moreover, Appellant does not offer any rationale for the proposition that Fagg's aqueous solvent of essentially pure water would be used only in the first extraction step and that a different aqueous solvent would be used in the middle fractionating step of the process. On its face, using different aqueous solvents, rather than the same essentially pure water solvent, in these steps appears to be an irrational complication serving no purpose. Finally, contrary to Appellant's apparent belief, Fagg's disclosure of water having bicarbonates as an acceptable aqueous solvent does not negate the disclosure that the aqueous solvent also "can be essentially pure water" (Fagg col. 3, 1. 34). Appellant observes correctly that "[b ]oth Yamada and JP 1 disclose controlling the tobacco extracted liquid to have a temperature at which denaturation of protein does not occur" (App. Br. 8). Appellant argues: Accordingly, the membrane separation at the temperature within a range of 40 to 80°C, including a temperature at which denaturation of protein occurs, would not have been easily conceived based on the teachings of the prior art references, which disclose only the membrane separation at a temperature at which denaturation of protein does not occur" (id. at 9). 6 Appeal2018-002396 Application 14/025,550 The deficiency of Appellant's argument is revealed by Appellant's accurate statement that "JP 1 discloses the tobacco extracted liquid is heated preferably at a temperature of 48°C or more and less than 52°C" (id. at 6 (see JP 1 translation un-numbered page 5)). This disclosure of JPl supports a conclusion that it would have been obvious to heat the extracted liquid of Yamada's fractionating treatment to a temperature in the JPl range of 48°C or more and less than 52°C. Temperatures in this range would achieve the desire of both Yamada and JP 1 to use temperatures at which denaturation of protein does not occur. These JP 1 temperatures satisfy the requirement of "a temperature within a range of 40 to 80°C" ( claim 1 ). In this latter regard, Appellant does not even allege much less show that claim 1 excludes temperatures at which denaturation of protein does not occur such as the temperatures disclosed by JP 1. For the reasons expressed in the Final Action, the Answer, and above, Appellant's arguments do not reveal error in the Examiner's§ 103 rejection of the claims on appeal. The decision of the Examiner is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 7 Copy with citationCopy as parenthetical citation